Download Sample
Add to CartGlobal Cell Harvesting Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
By Product;
Manual Cell Harvesters and Automated Cell Harvesters.By Application;
Biopharmaceutical, Stem Cell Research and Others.By End User;
Biotechnology & Biopharmaceutical Companies, Research Institutes, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).Introduction
Global Cell Harvesting Market (USD Million), 2020 - 2030
In the year 2023, the Global Cell Harvesting Market was valued at USD 898.08 million. The size of this market is expected to increase to USD 1,416.84 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.
According to a study published in Molecular Biomedical in February 2022, mesenchymal stem cells have demonstrated promising outcomes in clinical trials for treating COVID-19 by modulating the immune system. This increased adoption of stem cells in COVID-19 treatment significantly impacted market growth during the pandemic. With the easing of restrictions and resumption of company activities, the market is expected to witness growth over the forecast period.
The market is anticipated to expand due to factors such as increased investments in regenerative medicines and cell-based research. The growing incidence of chronic and infectious diseases, coupled with the expansion of the biotechnology and biopharmaceutical industries, is expected to drive market growth. Government initiatives aimed at accelerating research and development in regenerative medicine, such as Parvati and allocated, are also expected to boost demand for cell harvesters, thus augmenting market growth.
Government initiatives globally, such as the Stem Cell Therapies (SCT) Mission in Australia, which invested USD 150 million in March 2022 to develop innovative stem cell therapies, further support market expansion. Additionally, the rising incidence of chronic and infectious diseases, as highlighted by statistics from organizations like the Alzheimer's Association and BHS England Factsheet, underscores the need for effective biotechnology-based products and regenerative medicines, driving demand for cell harvesters.
The market is propelled by ongoing advancements and product launches by companies, which enhance the availability of advanced cell harvesting systems. For instance, in June 2022, researchers from the University of Technology Sydney collaborated with Regeneus to develop the first 3D-printed microfluidic stem cell harvesting system. Ethical concerns surrounding embryonic stem cell research may pose challenges to market growth over the forecast period.
Global Cell Harvesting Market Recent Developments & Report Snapshot
-
In October 2022, Thermo Fisher Scientific introduced the DynaSpin Single-Use Centrifuge system, a cutting-edge centrifuge tailored to offer an efficient single-use solution for large-scale cell culture harvesting. This innovative system enhances and simplifies the harvesting process by reducing the number of depth filtration cartridges needed to complete the harvest, thus streamlining operations and optimizing resource utilization.
-
In June 2022, a collaborative effort between researchers at the University of Technology Sydney and Regeneus resulted in the development of a novel 3D-printed microfluidic stem cell harvester. This groundbreaking device is engineered to extract stem cells from bioreactors, presenting a scalable approach to stem cell processing while mitigating associated expenses. By leveraging advanced 3D printing technology, this microfluidic harvester offers a cost-effective solution for harvesting stem cells, facilitating their utilization in various biomedical applications.
| Parameters | Description |
|---|---|
| Market | Global Cell Harvesting Market |
| Study Period | 2020 - 2030 |
| Base Year (for Cell Harvesting Market Size Estimates) | 2023 |
| Drivers |
|
| Restraints |
|
| Opportunities |
|
Segment Analysis
The cell harvesting, two primary product categories stand out: manual cell harvesters and automated cell harvesters. Manual cell harvesters are traditional tools used for collecting cells manually from various sources, providing researchers with direct control over the harvesting process. Automated cell harvesters leverage advanced technology to streamline and automate the cell harvesting process, offering increased efficiency and precision. Both manual and automated cell harvesters cater to the diverse needs of researchers and practitioners in the field, allowing for flexibility and customization in cell harvesting protocols.
The application of cell harvesting extends across various domains, with biopharmaceutical, stem cell research, and other applications representing significant areas of focus. In the biopharmaceutical sector, cell harvesting plays a crucial role in the production of biologics and therapeutic proteins, enabling the isolation and collection of target cells for further processing and analysis. Stem cell research relies heavily on efficient cell harvesting techniques to obtain and cultivate stem cells for various research purposes, including regenerative medicine and disease modeling. Additionally, cell harvesting finds applications in other fields such as tissue engineering, where the isolation of specific cell types is essential for constructing functional tissues and organs.
Biotechnology and biopharmaceutical companies, research institutes, and other end users constitute key stakeholders in the cell harvesting market. Biotechnology and biopharmaceutical companies utilize cell harvesting techniques to support drug discovery, development, and production processes, driving demand for advanced harvesting solutions. Research institutes play a pivotal role in advancing scientific knowledge and innovation, relying on efficient cell harvesting methods to conduct experiments and studies across diverse disciplines. Other end users, including academic institutions and healthcare facilities, also benefit from cell harvesting technologies in various research and clinical applications, contributing to the growth and expansion of the cell harvesting market.
Global Cell Harvesting Segment Analysis
In this report, the Global Cell Harvesting Market has been segmented by Product, Application, End User, and Geography.
Global Cell Harvesting Market, Segmentation by Product
The Global Cell Harvesting Market has been segmented by Product Type into Manual Cell Harvesters and Automated Cell Harvesters.
Manual cell harvesters typically involve labor-intensive processes where cells are manually collected using handheld devices or instruments. While manual cell harvesting methods may be suitable for certain applications, they are often associated with limitations such as variability in results, operator-dependent outcomes, and lower efficiency compared to automated alternatives.
Automated cell harvesters offer advanced capabilities and streamlined workflows for efficient and consistent cell harvesting. These automated systems are equipped with robotics, sensors, and software algorithms that enable precise and reproducible cell collection from biological samples. Automated cell harvesters are particularly well-suited for high-throughput applications in biopharmaceutical manufacturing, clinical diagnostics, and research laboratories, where large volumes of cells need to be harvested rapidly and reliably.
The choice between manual and automated cell harvesters depends on various factors such as the scale of operations, sample type, desired throughput, and level of automation required. While manual cell harvesters may be more cost-effective and suitable for small-scale or research-oriented applications, automated cell harvesters offer advantages in terms of efficiency, consistency, and scalability, making them ideal for industrial-scale production and clinical applications. As technology continues to evolve, advancements in automation and robotics are expected to further enhance the performance and capabilities of cell harvesting systems, driving innovation and growth in the global market.
Global Cell Harvesting Market, Segmentation by Application
The Global Cell Harvesting Market has been segmented by Application into Biopharmaceutical Application, Stem Cell Research and Others.
The stem cell research segment is poised for substantial growth in the cell harvesting market over the forecast period, driven by various factors including increased investment in stem cell research due to its potential in addressing numerous incurable diseases. Heightened company engagements in this field further contribute to the segment's expansion.
The surge in stem cell research studies and associated funding plays a pivotal role in bolstering the segment's growth trajectory. For instance, data from the National Institutes of Health (NIH) reveals a notable increase in government funding for stem cell research in the United States, reaching USD 2,279 million in 2022 compared to USD 2,186 million in the previous year. Additionally, initiatives like the Australian Stem Cell Mission, which received USD 18.7 million in funding in June 2021, underscore the commitment to advancing stem cell-based therapies to enhance health outcomes.
Companies are intensifying their focus on strategic initiatives such as acquisitions, collaborations, and product launches to enhance the availability of stem cell-based treatments in the market. Such efforts are expected to further drive growth in the segment. For instance, Jasper Therapeutics, Inc. entered a significant business combination agreement with Amplitude Healthcare Acquisition Corporation in May 2021, involving a transaction worth USD 100 million. This collaboration aims to accelerate the development of breakthrough stem cell-based therapies, including Jasper's pioneering anti-CD117 antibody transplant conditioning agent and engineered hematopoietic stem cell platform.
The convergence of increasing research endeavors, heightened company activities, and strategic product launches are poised to fuel the growth of the stem cell research segment in the cell harvesting market in the foreseeable future.
Global Cell Harvesting Market, Segmentation by End User
The Global Cell Harvesting Market has been segmented by End User into Pharmaceutical Companies, Biotechnology Companies, Research Institutes and Others.
Pharmaceutical companies constitute a significant portion of the end-user segment, leveraging cell harvesting technologies for various applications, including drug discovery, development, and production. These companies rely on cell harvesting techniques to obtain high-quality cells for therapeutic purposes, such as the production of biologics and cell-based therapies. With the increasing demand for innovative treatments and personalized medicine, pharmaceutical companies continue to invest in advanced cell harvesting technologies to support their research and development efforts.
Biotechnology companies also play a crucial role in driving the demand for cell harvesting technologies. These companies are engaged in the development of novel biologics, including monoclonal antibodies, recombinant proteins, and gene therapies, which often require the harvesting of specific cell types. By utilizing advanced cell harvesting systems, biotechnology companies can efficiently obtain the desired cells for their therapeutic products, contributing to advancements in the biopharmaceutical industry. Additionally, the growing focus on precision medicine and targeted therapies further underscores the importance of cell harvesting technologies in biotechnology research and development.
Research institutes represent another key segment of the end-user market for cell harvesting technologies. These institutions are at the forefront of scientific discovery and innovation, conducting fundamental research in various fields, including stem cell biology, tissue engineering, and regenerative medicine. Cell harvesting techniques are integral to many research projects aimed at understanding cell behavior, studying disease mechanisms, and developing novel therapies. By investing in cutting-edge cell harvesting technologies, research institutes can enhance their capabilities and accelerate scientific breakthroughs, ultimately driving progress in healthcare and biotechnology.
Global Cell Harvesting Market, Segmentation by Geography
In this report, the Global Cell Harvesting Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Cell Harvesting Market Share (%), by Geographical Region, 2023
North America is poised to command a significant portion of the cell harvesting market in the coming years, driven by various factors. One such factor is the escalating investment in regenerative medicines, coupled with the burgeoning biotechnology and biopharmaceutical industry within the region. Additionally, the presence of key market players further strengthens North America's position in this market segment. With substantial investments pouring into the research and development of innovative therapies, the demand for advanced cell harvesting systems is expected to witness a notable surge, thus propelling market growth.
The rising prevalence of chronic diseases like cancer, Alzheimer's disease, and retinal diseases, alongside the increasing focus on stem cell research for therapeutic applications, augments the demand for effective treatment modalities. As research endeavors continue to explore the potential of stem cells in addressing various ailments, the need for robust cell harvesting systems becomes paramount. Notably, clinical studies showcasing the promising outcomes of stem cell-based therapies, such as PEC-Direct for type 1 diabetes management, underscore the significance of advancements in cell harvesting technologies in facilitating innovative treatment approaches.
The influx of companies channeling resources into research and development endeavors aimed at advancing biotechnology products further catalyzes growth in the biotechnology and biopharmaceutical sector. Through strategic collaborations, investments, acquisitions, and other business initiatives, companies are enhancing the availability of regenerative medicines and cell-based products in the market. These concerted efforts contribute significantly to expanding the market landscape and fostering innovation in cell harvesting technologies. As a result, the cell harvesting market is poised to witness substantial growth over the forecast period, driven by the synergistic interplay of research advancements, industry activities, and evolving healthcare needs.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Cell Harvesting Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Growth of Cell-Based Therapies
- Expansion of Regenerative Medicine
-
Biomanufacturing Advancements - Biomanufacturing advancements are being driven by several key factors that are shaping the landscape of cell harvesting technologies. Firstly, the growing demand for biopharmaceuticals and regenerative medicines is a major driver. As the biopharmaceutical industry continues to expand rapidly, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology, there is a parallel need for efficient and scalable biomanufacturing processes. Cell harvesting plays a crucial role in this context by enabling the extraction of high-quality cells or cell products, which are essential for the production of biopharmaceuticals and other therapeutic products. The emergence of novel cell-based therapies, such as gene therapies and cell-based immunotherapies, further underscores the importance of advanced cell harvesting technologies in biomanufacturing.
Technological innovations and advancements are driving the development of more sophisticated cell harvesting systems. These innovations include improvements in automation, miniaturization, and integration with other bioprocessing technologies. For example, the integration of robotics and microfluidics has enabled the development of high-throughput cell harvesting platforms capable of processing large volumes of cells with high precision and efficiency. Similarly, advancements in imaging technologies and sensor technologies have enhanced the real-time monitoring and control of cell harvesting processes, leading to improved product quality and process efficiency. Such technological advancements are driving the adoption of advanced cell harvesting systems across various biomanufacturing applications, thereby fueling the growth of the market.
Regulatory initiatives and quality standards are playing a significant role in driving advancements in cell harvesting technologies for biomanufacturing. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established stringent guidelines and requirements for the manufacturing of biopharmaceutical products, including cell-based therapies. Compliance with these regulations necessitates the use of robust and reliable cell harvesting technologies that ensure the consistent and reproducible production of high-quality cell products. As a result, biomanufacturers are increasingly investing in advanced cell harvesting systems that meet regulatory standards and support the development and commercialization of innovative biopharmaceutical products.
Restraints:
- High Cost of Equipment and Consumables
- Ethical Considerations for Primary Cell Sources
-
Complexity of Techniques - The complexity of techniques poses a significant restraint in the field of cell harvesting. Many of the existing cell harvesting techniques involve intricate procedures that require specialized skills and equipment. For instance, manual cell harvesting methods often involve tedious and time-consuming processes, which can lead to inefficiencies and inconsistencies in cell yield and quality. These manual techniques may also carry a higher risk of contamination, particularly in sterile environments such as cleanrooms or laboratories. The complexity of techniques in cell harvesting can result in high operational costs for both equipment and personnel.
Automated cell harvesting systems, while offering potential improvements in efficiency and consistency, often require substantial upfront investment in specialized equipment and infrastructure. The maintenance and operation of these automated systems may require trained personnel, adding to the operational expenses. As a result, the adoption of advanced cell harvesting techniques may be limited by budgetary constraints, particularly for smaller research laboratories or healthcare facilities with limited resources. The complexity of techniques in cell harvesting can also present challenges in standardization and reproducibility. Variability in cell harvesting procedures, such as differences in harvesting protocols or equipment settings, can lead to inconsistencies in cell yield, viability, and quality between different batches or experiments. This lack of standardization can hinder the comparability of results across studies or laboratories, complicating data interpretation and reproducibility efforts. As a result, researchers and clinicians may face difficulties in accurately assessing the efficacy and safety of cell-based therapies or in reliably reproducing experimental results, thus impeding progress in the field of cell harvesting and regenerative medicine.
Opportunities:
- Emerging Cell Sources
- Development of Novel Harvesting Technologies
-
Growing Focus on Closed-Loop Systems - Closed-loop systems offer enhanced efficiency and precision in cell harvesting processes. By automating and controlling various parameters such as flow rates, temperatures, and cell concentrations, these systems minimize human error and variability, resulting in more consistent and reliable cell yields. This increased reliability not only improves the quality of harvested cells but also streamlines the harvesting process, saving time and resources for researchers and biopharmaceutical manufacturers.
Closed-loop systems enable real-time monitoring and feedback, allowing for dynamic adjustments during the harvesting process. This capability enhances process control and optimization, leading to higher yields and better cell quality. Additionally, real-time monitoring facilitates early detection of deviations or irregularities, enabling prompt corrective actions to maintain process integrity and product quality. As a result, closed-loop systems contribute to greater process robustness and reliability, reducing the risk of batch failures and ensuring consistent product quality.
The adoption of closed-loop systems supports the scalability and commercialization of cell-based therapies. As the demand for these therapies continues to rise, particularly in areas such as regenerative medicine and immuno-oncology, there is a growing need for efficient and scalable cell harvesting solutions. Closed-loop systems offer the scalability required to meet increasing production demands while maintaining process consistency and product quality. By enabling seamless scale-up from research to clinical and commercial manufacturing, closed-loop systems facilitate the translation of cell-based therapies from the laboratory to the clinic, ultimately benefiting patients in need of innovative treatments.
Competitive Landscape Analysis
Key players in Global Cell Harvesting Market include:
- PerkinElmer
- Brandel
- TOMTEC
- Cox Scientific
- Connectorate
- Scinomix
- ADSTEC
- Terumo BCT
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Cell Harvesting Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growth of Cell-Based Therapies
- Expansion of Regenerative Medicine
- Biomanufacturing Advancements
- Drivers
- Restraints
- Complexity of Techniques
- High Cost of Equipment and Consumables
- Ethical Considerations for Primary Cell Sources
- Opportunities
- Emerging Cell Sources
- Development of Novel Harvesting Technologies
- Growing Focus on Closed-Loop Systems
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Cell Harvesting Market, By Product, 2022 - 2032 (USD Million)
- Manual Cell Harvesters
- Automated Cell Harvesters
- Global Cell Harvesting Market, By Application, 2022 - 2032 (USD Million)
- Biopharmaceutical
- Stem Cell Research
- Others
- Global Cell Harvesting Market, By End User, 2022 - 2032 (USD Million)
- Biotechnology & Biopharmaceutical Companies
- Research Institutes
- Others
- Global Cell Harvesting Market, By Geography, 2022 - 2032 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Cell Harvesting Market, By Product, 2022 - 2032 (USD Million)
- Competitive Landscape
- Company Profiles
- PerkinElmer
- Brandel
- TOMTEC
- Cox Scientific
- Connectorate
- Scinomix
- ADSTEC
- Terumo BCT
- Company Profiles
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Cell Isolation Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Cell Lysis/Cell Fractionation Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Cell Proliferation Kit Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Cell Therapy Technologies Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%